Community-based screening for chronic kidney disease, hypertension and diabetes in dharan

Journal of the Nepal Medical Association

Volumn 52, Issue 5, 2013, Pages 205-212

  Sharma, Sanjib Kumar ^a   Dhakal, Subodh ^a   Thapa, Lekhjung ^a   Ghimire, Anup ^a   Tamrakar, Rikesh ^a   Chaudhary, Satdal ^a   Deo, Rajib ^a   Manandhar, Dhiraj ^a   Perico, Norberto ^b   Perna, Annalisa ^b   Remuzzi, Giuseppe ^a   Lamsal, Madhav ^a  

^a B P KOIRALA INSTITUTE OF HEALTH SCIENCES   (Nepal)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Chronic kidney disease; Community screening; Diabetes; Hypertension; Intervention; Nepal

Indexed keywords

CREATININE; GLUCOSE;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; EDUCATIONAL STATUS; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLUCOSE URINE LEVEL; GLYCEMIC CONTROL; HEALTH PROGRAM; HEALTH STATUS; HEALTH SURVEY; HUMAN; HYPERTENSION; INTERVENTION STUDY; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NEPAL; OBESITY; PATIENT COUNSELING; PHYSICAL EXAMINATION; PREDICTION; PREVALENCE; PROTEIN URINE LEVEL; PROTEINURIA; SMOKING; SYSTOLIC BLOOD PRESSURE; TREND STUDY; UNDERWEIGHT;

EID: 84876352153     PISSN: 00282715     EISSN: None     Source Type: Journal    
DOI: 10.31729/jnma.548     Document Type: Article

References (34)

1. UNDP. United Nations Development Programme Report 2006. [Online]. 2006 [cited 2007 Jul 4]; Available from: URL:http://hdr.undp.org/reports/global/2006/pdf/HDR06_HDI.pdf
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003 May 21;289(19):2560-72.
3. WHO. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004 Jan 10;363(9403):157-63.
4. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003 Jan;26 Suppl 1:S5-20.
5. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999 Mar 16;130(6):461-70.
6. Kawasaki T, Ogaki T, Itoh K, Shigeru K, Tetsurou O. The significance of the daily mineral intake (sodium, potassium, calcium and magnesium) on the genesis of hypertension in Nepal. Journal of Health Sciences. 1998;20:109-18.
7. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002 feb;39(2 suppl 1):S1-266.
8. Hoy WE, Mathews JD, McCredie DA, Pugsley DJ, Hayhurst BG, Rees M, et al. The multidimensional nature of renal disease: rates and associations of albuminuria in an Australian Aboriginal community. Kidney Int. 1998 oct;54(4):1296-304.
9. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med. 2001;134(8):629-36.
10. Caballero B. A nutrition paradox-underweight and obesity in developing countries. N Engl J Med. 2005;352:1514-16.
11. Smith C. Blood pressures of Sherpa men in modernizing Nepal. Am J Hum Biol. 1999;11(4):469-479.
12. Pandey MR. Hypertension in Nepal. Bibl Cardiol. 1987;(42):68-76.
13. Singh DL, Bhattarai MD. High prevalence of diabetes and impaired fasting glycaemia in urban Nepal. Diabet Med. 2003;20(2):170-1.
14. King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults: WHO Ad Hoc Diabetes Reporting Group. Diabetes Care. 1993;16:157-77.
15. Sasaki H, Kawasaki T, Ogaki T, Shigeru K, Itoh K, Yoshimizu Y et al. The prevalence of diabetes mellitus and impaired fasting glucose/glycaemia (IFG) in suburban and rural Nepal the communities--based cross-sectional study during the democratic movements in 1990. Diabetes Res Clin Pract. 2005;67:167-74.
16. Carel RS, Silverberg DS, Kaminsky R, Aviram A. Routine urinalysis (dipstick) findings in mass screening of healthy adults. Clin Chem. 1987;33:2106-8.
17. Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003;63:1468-74.
18. Agarwal SK, Dash SC, Irshad M, Raju S, Singh R, Pandey RM. Prevalence of chronic renal failure in adults in Delhi, India. Nephrol Dial Transplant. 2005;20:1638-42.
19. Ramirez SP, Hsu SI, McClellan W. Taking a public health approach to the prevention of end-stage renal disease: the NKF Singapore Program. Kidney Int Suppl. 2003;S61-65.
20. Li PK, Kwan BC, Leung CB, Kwan TH, Wong KM, Lui SL et al. Prevalence of silent kidney disease in Hong Kong: the screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) program. Kidney Int Suppl. 2005;S36-40.
21. Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ et al. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol. 2003;14:S131-8.
22. Zhang L, Zuo L, Xu G, et al. Community-based screening for chronic kidney disease among populations older than 40 years in Beijing. Nephrol Dial Transplant. 2007;22:1093-9.
23. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1-12.
24. Konta T, Hao Z, Abiko H, Wang M, Wang S, Lv J et al. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study. Kidney Int. 2006;70:751-6.
25. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End-stage renal disease in African-American and white men 16-year MRFIT findings. Jama. 1997;277:1293-8.
26. Schaeffner ES, Kurth T, Curhan GC, Glynn RJ, Rexrode KM, Baigent C et al. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol. 2003;14:2084-91.
27. Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J. Risk factors for chronic kidney disease: a prospective study of 23, 534 men and women in Washington County, Maryland. J Am Soc Nephrol. 2003;14:2934-41.
28. Iseki K. The okinawa screening program. J Am Soc Nephrol.2003;14:S127-30.
29. Ruggenenti P, Fassi A, Ilieva AP, Bruno S, Illiev IP, Brusegan V et al. Preventing microalbuminuria in type 2 diabetes. N Engl J Med. 2004;351:1941-51.
30. Ruggenenti P, Perna A, Ganeva M, Ene-Iordache B, Remuzzi G. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial. J Am Soc Nephrol. 2006;17:3472-81.
31. Ravid M, Brosh D, Levi Z, Bar-Dayan Y, Ravid D, Rachmani R. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus: A randomized, controlled trial. Ann Intern Med. 1998;128:982-8.
32. Adler AI, Stratton IM, Neil HA, Yudkind JS, Methews DR, Cull CA et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321:412-9.
33. Stratton IM, Adler AI, Neil HA, Mathews DR, MAnley AC, Cull CA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-12.
34. Pavkov ME, Knowler WC, Bennett PH, Looker HC, Krakoff J, Nelson RG. Increasing incidence of proteinuria and declining incidence of end-stage renal disease in diabetic Pima Indians. Kidney Int. 2006;70:1840-6.